Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
Viruses ; 13(1)2021 Jan 14.
Article in English | MEDLINE | ID: mdl-33466915

ABSTRACT

Mosquito-borne arthropod-borne viruses (arboviruses) such as the dengue virus (DENV), Zika virus (ZIKV), and chikungunya virus (CHIKV) are important human pathogens that are responsible for significant global morbidity and mortality. The recent emergence and re-emergence of mosquito-borne viral diseases (MBVDs) highlight the urgent need for safe and effective vaccines, therapeutics, and vector-control approaches to prevent MBVD outbreaks. In nature, arboviruses circulate between vertebrate hosts and arthropod vectors; therefore, disrupting the virus lifecycle in mosquitoes is a major approach for combating MBVDs. Several strategies were proposed to render mosquitoes that are refractory to arboviral infection, for example, those involving the generation of genetically modified mosquitoes or infection with the symbiotic bacterium Wolbachia. Due to the recent development of high-throughput screening methods, an increasing number of drugs with inhibitory effects on mosquito-borne arboviruses in mammalian cells were identified. These antivirals are useful resources that can impede the circulation of arboviruses between arthropods and humans by either rendering viruses more vulnerable in humans or suppressing viral infection by reducing the expression of host factors in mosquitoes. In this review, we summarize recent advances in small-molecule antiarboviral drugs in mammalian and mosquito cells, and discuss how to use these antivirals to block the transmission of MBVDs.


Subject(s)
Aedes/virology , Antiviral Agents/pharmacology , Arbovirus Infections/transmission , Arbovirus Infections/virology , Arboviruses/drug effects , Mosquito Vectors/virology , Aedes/drug effects , Animals , Antiviral Agents/chemistry , Antiviral Agents/therapeutic use , Arbovirus Infections/drug therapy , Arboviruses/classification , Cells, Cultured , Drug Discovery/methods , Drug Evaluation, Preclinical , Humans , Mosquito Control/methods , Vector Borne Diseases/drug therapy , Vector Borne Diseases/transmission , Vector Borne Diseases/virology , Virus Replication/drug effects
2.
Molecules ; 25(15)2020 Jul 31.
Article in English | MEDLINE | ID: mdl-32751878

ABSTRACT

The mosquito species Aedes aegypti is one of the main vectors of arboviruses, including dengue, Zika and chikungunya. Considering the deficiency or absence of vaccines to prevent these diseases, vector control remains an important strategy. The use of plant natural product-based insecticides constitutes an alternative to chemical insecticides as they are degraded more easily and are less harmful to the environment, not to mention their lower toxicity to non-target insects. This review details plant species and their secondary metabolites that have demonstrated insecticidal properties (ovicidal, larvicidal, pupicidal, adulticidal, repellent and ovipositional effects) against the mosquito, together with their mechanisms of action. In particular, essential oils and some of their chemical constituents such as terpenoids and phenylpropanoids offer distinct advantages. Thiophenes, amides and alkaloids also possess high larvicidal and adulticidal activities, adding to the wealth of plant natural products with potential in vector control applications.


Subject(s)
Aedes/drug effects , Arbovirus Infections/prevention & control , Arboviruses/physiology , Biological Products/pharmacology , Insect Repellents/pharmacology , Insecticides/pharmacology , Mosquito Control/methods , Mosquito Vectors/drug effects , Plant Extracts/pharmacology , Aedes/virology , Animals , Arbovirus Infections/transmission , Arbovirus Infections/virology , Biological Products/chemistry , Insect Repellents/chemistry , Insecticides/chemistry , Oils, Volatile/pharmacology , Oviposition/drug effects , Plant Extracts/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL